The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Outcomes of patients with advanced sarcoma enrolled in clinical trials of pazopanib in combination with histone deacetylase, mTOR, Her2, or MEK inhibitors.
 
Vikas Dembla
Speakers' Bureau - Bayer/Onyx; Bristol-Myers Squibb
 
Siqing Fu
No Relationships to Disclose
 
Jennifer Wheler
No Relationships to Disclose
 
David S. Hong
Research Funding - Amgen; AstraZeneca; Daiichi Sankyo; Eisai; Genentech; Lilly; Merck; Mirati Therapeutics; miRNA Therapeutics; Novartis; Pfizer
Travel, Accommodations, Expenses - Loxo; miRNA Therapeutics
 
Filip Janku
Consulting or Advisory Role - Deciphera; Trovagene
Research Funding - Biocartis; BioMed Valley Discoveries; Foundation Medicine; Novartis; Roche; Trovagene
Other Relationship - Bio-Rad
 
Ralph Zinner
No Relationships to Disclose
 
Sarina Anne Piha-Paul
No Relationships to Disclose
 
Vinod Ravi
No Relationships to Disclose
 
Robert S. Benjamin
Stock and Other Ownership Interests - Express Scripts (I); Gilead Sciences (I); Johnson & Johnson (I); Merck Serono (I); Pfizer (I)
Consulting or Advisory Role - Karyopharm Therapeutics; Lilly; Novartis
Travel, Accommodations, Expenses - PharmaMar
 
Shreyaskumar Patel
Consulting or Advisory Role - CytRx Corporation; Daiichi Sankyo; EMD Serono; Johnson & Johnson; Novartis
Research Funding - Eisai (Inst); Johnson & Johnson (Inst); Morphotek (Inst); PharmaMar (Inst)
 
Neeta Somaiah
Honoraria - Immune Design
Travel, Accommodations, Expenses - Immune Design
 
Cynthia E. Herzog
No Relationships to Disclose
 
Daniel D. Karp
No Relationships to Disclose
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche
Consulting or Advisory Role - Celgene; Genentech; Inflection Biosciences; Novartis; Roche
Research Funding - Aileron Therapeutics; AstraZeneca; Bayer; Calithera Biosciences; CytomX Therapeutics; Debiopharm Group; Genentech; Novartis; PUMA Biotechnology; Taiho Pharmaceutical; Verastem
 
Vivek Subbiah
No Relationships to Disclose